Results 251 to 260 of about 2,431,681 (314)

Five‐Year Disease Progression in Synuclein Seeding Positive Sporadic Parkinson's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To provide a comprehensive description of disease progression in synuclein seeding assay (SAA) positive sporadic Parkinson Disease participants, using Neuronal Synuclein Disease integrated biological and functional impairment staging framework.
Paulina Gonzalez‐Latapi, Caroline Gochanour, Seung Ho Choi, Hyunkeun Cho, Chelsea Caspell‐Garcia, Christopher Coffey, Michael Brumm, David‐Erick Lafontant, Yuge Xiao, Thomas Tropea, John Seibyl, Caroline Tanner, Charles S. Venuto, Karl Kieburtz, Lana M. Chahine, Kathleen L. Poston, Andrew Siderowf, Kenneth Marek, Tanya Simuni, The Parkinson's Progression Markers Initiative   +19 more
wiley   +1 more source

From water to land-Usage of Generalized Unified Threshold models of Survival (GUTS) in an above-ground terrestrial context exemplified by honeybee survival data. [PDF]

Environ Toxicol Chem
Bürger LU, Focks A.
europepmc   +1 more source

Value of MRI Outcomes for Preventive and Early‐Stage Trials in Spinocerebellar Ataxias 1 and 3

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To examine the value of MRI outcomes as endpoints for preventive and early‐stage trials of two polyglutamine spinocerebellar ataxias (SCAs). Methods A cohort of 100 participants (23 SCA1, 63 SCA3, median Scale for the Assessment and Rating of Ataxia (SARA) score = 5, 42% preataxic, and 14 gene‐negative controls) was scanned at 3T up ...
Thiago J. R. Rezende, Emilien Petit, Young Woo Park, Sophie Tezenas du Montcel, James M. Joers, Jonathan M. DuBois, H. Moore Arnold, Michal Povazan, Ipek Özdemir, Guita Banan, Romain Valabregue, Philipp Ehses, Jennifer Faber, Chiadi U. Onyike, Peter B. Barker, Jeremy D. Schmahmann, Eva‐Maria Ratai, Sub H. Subramony, Thomas H. Mareci, Khalaf O. Bushara, Henry Paulson, Thomas Klockgether, Alexandra Durr, Tetsuo Ashizawa, Christophe Lenglet, Gülin Öz, READISCA Investigators   +26 more
wiley   +1 more source

Predictive Model of Gemtuzumab Ozogamicin Response in Childhood Acute Myeloid Leukemia on Event-Free Survival: Data Analysis Based on Trial AAML0531. [PDF]

Bioengineering (Basel)
Qiu KY, Liao XY, Fang JP, Zhou DH.
europepmc   +1 more source

ctGAN: combined transformation of gene expression and survival data with generative adversarial network. [PDF]

Brief Bioinform
Kim J, Seok J.
europepmc   +1 more source

Topics in the statistical analysis of positive and survival data

, 1998
Kelly, Jodie
core  

Results of Endometrial Biopsy and Its Impact on Survival Data in Patients with High-Risk Uterine Sarcoma. [PDF]

J Clin Med
Alwafai Z, Reichert VMC, Spring P, Zygmunt M, Köhler G.   +4 more
europepmc   +1 more source

Derivation of a comprehensive semi-empirical proton RBE model from published experimental cell survival data collected in the PIDE database. [PDF]

Front Oncol
Jin JY, Yuan J, Qin X, Li Y, Yan H, Oleinick NL, Yao M, Pan Q, Kong FS, Machtay M.   +9 more
europepmc   +1 more source

Ambulatory Routine Care in Oncology in Germany: Real-World Survival Data.

Oncol Res Treat
Marschner N, Knauf W.
europepmc   +1 more source